With increasing frequency over the past few years, optometrists across the country have gotten referrals from internists requesting baseline diabetic retinopathy (DR) screenings for patients about to start therapy with one of the glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists such as semaglutide (Ozempic, Novo Nordisk), tirzepatide (Mounjaro, Eli Lilly) and dulaglutide (Trulicity, Eli Lilly
Intravenous therapy bypasses these problems completely, delivering nutrients directly
Remember, GLP-1 slows down your digestive tract
A healthcare professional may recommend taking certain supplements if youre taking GLP-1 medications
Its administered via intravenous (IV) injections or oral supplements
3 Benefits of the Original Prescription Appetite Suppressant Phentermine January 8, 2025 John Bergeron MD GLP-1 medications were first approved by the FDA for weight loss in 2021